Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial

BACKGROUND: The optimal intravenous (IV) iron would allow safe correction of iron deficiency at a single infusion over a short time. The FERWON-NEPHRO trial evaluated the safety and efficacy of iron isomaltoside 1000/ferric derisomaltose (IIM) in patients with non-dialysis-dependent chronic kidney d...

Full description

Saved in:
Bibliographic Details
Published in:Nephrol Dial Transplant
Main Authors: Bhandari, Sunil, Kalra, Philip A, Berkowitz, Mario, Belo, Diogo, Thomsen, Lars L, Wolf, Myles
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
ORIGINAL ARTICLES
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7771981/
https://ncbi.nlm.nih.gov/pubmed/32049331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfaa011
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items